Compound Detail
CHEMBL101371
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL101371 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZJNVFBLZPCRQOR-UHFFFAOYSA-N |
1
Targets
2
Activities
2
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
323.4
MW (Da)
1.83
ALogP
6
HBA
2
HBD
98.2
PSA (Ų)
0.75
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 8.09
Ki 1 meas. best 8.09
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Carbonic anhydrase 2 CHEMBL205 | IC50 | 8.09 | 8.09 | 8.2 | 1 |
| Carbonic anhydrase 2 CHEMBL205 | Ki | 8.09 | 8.09 | 8.2 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Carbonic anhydrase 2 | IC50 | = | 8.2 | nM | 8.09 | Inhibition of human erythrocyte carbonic anhydrase II | 1501230 |
| Carbonic anhydrase 2 | Ki | = | 8.2 | nM | 8.09 | Compound was evaluated for the inhibition of dansylamide at human carbonic anhyd... | 1501230 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 1501230 | 10.1021/jm00094a016 | No relevant target | 5 |
| 1501230 | 10.1021/jm00094a016 | Carbonic anhydrase 2 | 3 |
| 1501230 | 10.1021/jm00094a016 | Bos taurus | 1 |
Data from ChEMBL 36 via Core Engine